vimarsana.com

Page 2 - ஆரோக்கியம் தரகு ஆஃப் யுன்னன் மாகாணம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China Blood Products Market Report 2021 - COVID-19 Pandemic Brings Development Opportunities to Domestic Companies

Share this article Share this article ResearchAndMarkets.com s offering. With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which has further opened up the blood product market. In 2020, the lot release volume of blood products in China sustained growth, hitting 101.31 million bottles, a year-on-year upsurge of 12.7%. Wherein, the lot release volume of human albumin rose 14.78% on an annualized basis, making up 60%; that of human immunoglobulin (pH4) for intravenous injection as a percentage of 12.92% in the total showed a year-on-year increase of 11.78%; that of human tetanus immunoglobulin soared by 76.7% and accounted for 6.9%; other products like human fibrinogen, human prothrombin complex and human coagulation factor VIII took relatively low shares.

Chinese city on border with Myanmar reports 6 new COVID-19 cases

10 Apr 2021 / 08:59 H. SHANGHAI, April 1 (Reuters) - Health authorities in China s southwestern Yunnan province said on Thursday six new confirmed COVID-19 cases were reported in Ruili city that borders Myanmar on March 31, amid efforts to contain a new outbreak there. The city put residents in its urban area into home quarantine, began restricting people and vehicles exit from the city and began a mass screening drive on Wednesday after reporting six new COVID-19 cases and three asymptomatic patients - those who are infected with the novel coronavirus but do not show symptoms of the disease. Two of the new confirmed COVID-19 patients and 10 of the asymptomatic patients are Myanmar citizens, the Health Commission of Yunnan Province said in a statement.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.